Healthcare -
Biotechnology - NASDAQ - US
$ 17.23
-2 %
$ 462 M
Market Cap
-110.87
P/E
INCOME STATEMENT
EFFICIENCY
Earnings Waterfall
Eton Pharmaceuticals, Inc.
| Revenue | 39 M |
| Cost Of Revenue | 15.6 M |
| Gross Profit | 23.4 M |
| Operating Expenses | 26 M |
| Operating Income | -2.6 M |
| Other Expenses | 1.23 M |
| Net Income | -3.82 M |
Income Statement
Millions
| Dec-2024 | Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | |
|---|---|---|---|---|---|---|---|---|
| REVENUE | ||||||||
| Revenue | 39.0 | 31.6 | 21.3 | 21.8 | 39 K | 1.0 | 0 | 0 |
| GROSS PROFIT | ||||||||
| Cost Of Revenue | 15.6 | 10.6 | 6.9 | 2.6 | 0.3 | 0.5 | 63 K | 13 K |
| Gross Profit | 23.4 | 21.1 | 14.3 | 19.2 | (0.2) | 0.5 | 63 K | 13 K |
| OPERATING INCOME | ||||||||
| Operating Expenses | 26.0 | 22.3 | 22.6 | 20.7 | 26.9 | 19.1 | 10.3 | 7.1 |
| Selling, General and Administrative Expenses | 22.8 | 18.9 | 18.6 | 14.5 | 12.8 | 7.6 | 4.7 | 3.2 |
| Research and Development Expenses | 3.3 | 3.3 | 4.0 | 6.2 | 14.1 | 11.6 | 5.6 | 3.9 |
| Operating Income | (2.6) | (1.2) | (8.3) | (1.5) | (27.1) | (18.6) | (10.3) | (7.2) |
| PRE-TAX INCOME | ||||||||
| Interest Income Expense | 0 | 0 | 1.0 | 1.0 | 0.9 | 0 | 0 | 0 |
| Total Other Income | (1.2) | 0.5 | (0.8) | (0.5) | (0.9) | 0.3 | (2.4) | 6 K |
| Pre-Tax Income | (3.8) | (0.7) | (9.0) | (2.0) | (28.0) | (18.3) | (12.7) | (7.2) |
| NET INCOME | ||||||||
| Tax Provision | 15 K | 0.2 | 0.8 | 1.0 | 0.9 | (0.3) | (2.6) | 0 |
| Net Income | (3.8) | (0.9) | (9.8) | (3.0) | (28.8) | (18.0) | (12.7) | (7.2) |
| EPS | 0.15 | 0.0365 | 0.39 | 0.12 | 1.37 | 1.02 | 1.99 | 0.41 |